CompoAtlas

Palmitoyléthanolamide SEVIPHARM 400 mg - 90 gélules

Food supplement declared in France, decision dated 20 August 2025

Palmitoyléthanolamide SEVIPHARM 400 mg - 90 gélules, from DITRAGEN DEVELOPMENT, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Palmitoyléthanolamide 1,200 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
SEVIPHARM
Food business operator placing the product on the market
DITRAGEN DEVELOPMENT
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
1 à 3 gélules
Directions for use
Prendre 1 à 3 gélules par jour, à avaler avec un grand verre d’eau
Intended populations
Men and women aged 18 and over, People over 60
Not recommended (according to the manufacturer)
Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Children (under 6), Children (under 10)
Objectives stated by the manufacturer (these are not authorised claims)
Mood, Sleep, Nervous system, Joints
Flavourings
Sans saveur

Declaration 338965, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Substances

NamePer day
Palmitoyléthanolamide1,200 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

• Les compléments alimentaires doivent être utilisés dans le cadre d’un mode de vie sain et ne pas être utilisés comme substituts d’un régime alimentaire varié et équilibré • Ne pas dépasser la dose journalière indiquée • Tenir hors de portée des jeunes enfants • Ce produit est déconseillé aux femmes enceintes ou allaitantes, aux personnes ayant des troubles de la déglutition (risque de fausse route), ainsi qu’aux enfants de moins de 12 ans • Conserver dans un endroit frais, sec et à l’abri de la lumière

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : SEVIPHARM

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Palmitoyléthanolamide SEVIPHARM 400 mg - 90 gélules: composition and regulation”, https://compoatlas.com/en/supplements/products/338965-palmitoylethanolamide-sevipharm-400-mg-90-gelules, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line